Zach's Run - 5K Run & Fun Walk

Zach’s Run 2008 is in Ocean City, NJ!

Our third annual 5K run and 1-mile family fun walk has relocated from Atlantic City to Ocean City, NJ. This year's event boasts a new 5k route along the Ocean City Boardwalk and Gardens section, a family fun walk, food, entertainment, awards, and, most importantly, check presentations for medical research.

Bring the whole family out to support Hunter Syndrome research and awareness. Also enjoy the annual auto show on the Ocean City Boardwalk later in the afternoon.

Zach's Run 2008 is on Saturday, October 4 beginning at 6th Street and the Boardwalk.

To register for the event, click here

Help make a difference and donate today.

Our proceeds support medical research. To donate, click here

Zachary Dearth, the event’s namesake, with friend Mykonos. Both are affected by Hunter Syndrome, MPS II.

Zach’s Run 2007 Raises Over $16,000

The 2007 Zach’s Run 5k Run and 1–Mile Fun Walk was held in Atlantic City, NJ on Sunday, September 30. The event, which drew over 400 people, raised over $16,000 during its second year. The event, since inception, has collected over $51,000 for medical research and awareness initiatives.

Plans for next year’s Zach’s Run are currently underway. The date and location will be announced in early 2008. In the meantime, to view photos of the event, click on the Photos link above or here.

If you participated in the event and would like to see the results of the run, click here.

Founders, Chris and Cheryl Dearth, present a check for $15,000 to North Carolina Children’s Hospital.

Zach’s Run Donates $25,000 for Medical Research

Two donations were granted for medical research initiatives at this year’s Zach’s Run. Making Precious Strides, Inc., the host of Zach’s Run, presented checks for $10,000 to the Children’s Hospital of Philadelphia and $15,000 to the North Carolina Children’s Hospital (bottom photo). Both hospitals are leading programs that specialize in MPS-related research.

Recent research and clinical trials have lead to the introduction of Elaprase, an enzyme replacement therapy that has proven to reduce the affects in MPS II patients. More information regarding these research efforts will be posted on our parent site, http://www.makingpreciousstrides.org/ in 2008.